|
CEO Pay
|
14
|
Resverlogix Corp.
|
Mar 31, 2022 02:33PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
13
|
Resverlogix Corp.
|
Mar 17, 2022 11:43PM
|
|
Re: The jaded group of posters
|
12
|
Resverlogix Corp.
|
Nov 01, 2021 01:22PM
|
|
Royalty Preferred Shares
|
12
|
Zenith Epigenetics
|
Nov 21, 2019 09:20PM
|
|
Re: New share price contest for end of year 2019
|
12
|
Resverlogix Corp.
|
Nov 20, 2019 11:35AM
|
|
Providence Therapeutics
|
12
|
Resverlogix Corp.
|
Sep 14, 2021 10:43AM
|
|
BTD
|
11
|
Resverlogix Corp.
|
Apr 23, 2022 01:47PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
11
|
Resverlogix Corp.
|
Dec 22, 2020 09:02AM
|
|
Re: New video quietly released
|
11
|
Resverlogix Corp.
|
Jan 29, 2022 08:36PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
11
|
Resverlogix Corp.
|
Mar 25, 2022 04:14PM
|
|
Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems
|
11
|
Zenith Epigenetics
|
Sep 17, 2020 11:46PM
|
|
Management performance
|
11
|
Resverlogix Corp.
|
Apr 27, 2021 12:06PM
|
|
Re: Question for posters
|
11
|
Resverlogix Corp.
|
Dec 09, 2021 12:35PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
10
|
Resverlogix Corp.
|
Dec 16, 2021 01:14PM
|
|
Re: Actual salaries paid
|
10
|
Resverlogix Corp.
|
May 22, 2021 06:19PM
|
|
Re: Prospects for resverlogix
|
10
|
Resverlogix Corp.
|
Jul 15, 2020 11:47AM
|
|
Re: More exposure
|
10
|
Resverlogix Corp.
|
May 20, 2021 01:38PM
|
|
Re: Deja Vu All Over Again
|
10
|
Resverlogix Corp.
|
Mar 11, 2022 03:19PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
10
|
Resverlogix Corp.
|
Mar 18, 2022 09:50PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
10
|
Resverlogix Corp.
|
May 09, 2022 10:46AM
|
